FEEDBACK
PLEASE WAIT ...
CLOSE
Forgot password?
Create New Account
CLOSE
LOGIN
CREATE NEW ACCOUNT
menu
HOME
HOME
Refine
Refine
companies
companies
Statnano.com
Statnano.com
Contact us
Product Submission
GO
ADVANCED SEARCH
Home
Products
ABRAXANE®
Manufacturer
Abraxis Bioscience
Country
USA
Certificates
FDA
Document
No Title
0.21
MB
Registration Date
10 Nov 2014
Share
ABRAXANE®
(4.5)
Medicine
Pharmaceuticals
Product Number : 68817-134-50
Antineoplastic Agent
Drug Information
Generic
PACLITAXEL
NDC Code
68817-134-50
Drug Class
Mitotic inhibitors
Therapeutic Class
Antineoplastic
Dosage form
Powder
Route of Administration
Intravenous Injection
Therapeutic Area
1.
Breast Cancer
2.
Lung Cancer
3.
Pancreatic Cancer
Nanomaterials
Manufacturer Asserted
Protein
Nanoparticle /Nanopowder
Benefit
Eliminates the use of toxic solvents that were essential for its microformulated counterpart